{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:54:46Z","timestamp":1792086886128,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jtha.2026.05.029","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T07:01:16Z","timestamp":1780556476000},"page":"3369-3391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass: guidance from the ISTH SSC on Perioperative and Critical Care Haemostasis and Thrombosis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9997-454X","authenticated-orcid":false,"given":"Allyson M.","family":"Pishko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4044-2674","authenticated-orcid":false,"given":"Cheryl L.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3766-4962","authenticated-orcid":false,"given":"Jerrold H.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6445-582X","authenticated-orcid":false,"given":"Jean M.","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.05.029_bib1","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1182\/blood-2016-01-635003","article-title":"How I treat patients with a history of heparin-induced thrombocytopenia","volume":"128","author":"Warkentin","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.029_bib2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1053\/j.jvca.2019.08.022","article-title":"Role of bivalirudin for anticoagulation in adult perioperative cardiothoracic practice","volume":"34","author":"Erdoes","year":"2020","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2026.05.029_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jtcvs.2005.09.057","article-title":"A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study","volume":"131","author":"Dyke","year":"2006","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib4","doi-asserted-by":"crossref","first-page":"e495S","DOI":"10.1378\/chest.11-2303","article-title":"Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Linkins","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.029_bib5","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.029_bib6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1213\/ANE.0000000000005721","article-title":"Survey of practice pattern in patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass","volume":"133","author":"Wanat-Hawthorne","year":"2021","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2026.05.029_bib7","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1055\/s-0039-3401825","article-title":"Outcomes of cardiovascular surgery utilizing heparin versus direct thrombin inhibitors in cardiopulmonary bypass in patients with previously diagnosed HIT","volume":"120","author":"Carlson","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.029_bib8","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/icvts\/ivx251","article-title":"Bivalirudin anticoagulation for left ventricular assist device implantation on an extracorporeal life support system in patients with heparin-induced thrombocytopenia antibodies","volume":"25","author":"Ljajikj","year":"2017","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s10047-015-0846-9","article-title":"Implantation of left ventricular assist devices under extracorporeal life support in patients with heparin-induced thrombocytopenia","volume":"18","author":"Hillebrand","year":"2015","journal-title":"J Artif Organs"},{"key":"10.1016\/j.jtha.2026.05.029_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.athoracsur.2006.09.038","article-title":"Bivalirudin during cardiopulmonary bypass in patients with previous or acute heparin-induced thrombocytopenia and heparin antibodies: results of the CHOOSE-ON trial","volume":"83","author":"Koster","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1213\/ANE.0b013e3181c3c1cd","article-title":"Plasmapheresis and heparin reexposure as a management strategy for cardiac surgical patients with heparin-induced thrombocytopenia","volume":"110","author":"Welsby","year":"2010","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2026.05.029_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.healun.2018.04.016","article-title":"Plasma exchange to remove heparin-induced thrombocytopenia antibodies and the use of heparin during cardiopulmonary bypass in critically ill cardiac patients","volume":"37","author":"Ramu","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtha.2026.05.029_bib13","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/vox.13008","article-title":"Clinical outcomes of cardiac surgery patients undergoing therapeutic plasma exchange for heparin-induced thrombocytopenia","volume":"116","author":"Moreno-Duarte","year":"2021","journal-title":"Vox Sang"},{"key":"10.1016\/j.jtha.2026.05.029_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/icvts\/ivaa196","article-title":"A combined approach to treat heparin-induced thrombocytopaenia before heart transplant","volume":"31","author":"Sandoval","year":"2020","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib15","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1097\/MAT.0000000000001631","article-title":"Management of heparin-induced thrombocytopenia using plasmapharesis in patients undergoing HeartMate 3 left ventricular assist device","volume":"68","author":"Naqvi","year":"1992","journal-title":"ASAIO J"},{"key":"10.1016\/j.jtha.2026.05.029_bib16","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0003-4975(00)02022-1","article-title":"Cardiac surgery with cardiopulmonary bypass in patients with type II heparin-induced thrombocytopenia","volume":"71","author":"Aouifi","year":"2001","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib17","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/cr.2000.5846","article-title":"Management of urgent high-risk cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and coexisting disorders of renal function: use of heparin and epoprostenol combined with on-line monitoring of platelet function","volume":"14","author":"Mertzlufft","year":"2000","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2026.05.029_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1097\/00000542-198812000-00030","article-title":"Heparin-associated thrombocytopenia: management of patients for open heart surgery. Case reports describing the use of iloprost","volume":"69","author":"Kraenzler","year":"1988","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2026.05.029_bib19","first-page":"354","article-title":"Cardiac surgery in patients with heparin-induced thrombocytopenia using preoperatively determined dosages of iloprost","volume":"5","author":"Antoniou","year":"2002","journal-title":"Heart Surg Forum"},{"key":"10.1016\/j.jtha.2026.05.029_bib20","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/ajh.24017","article-title":"Perioperative use of iloprost in cardiac surgery patients diagnosed with heparin-induced thrombocytopenia-reactive antibodies or with true HIT (HIT-reactive antibodies plus thrombocytopenia): an 11-year experience","volume":"90","author":"Palatianos","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.029_bib21","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1067\/mtc.2001.118271","article-title":"One-year experience with the platelet glycoprotein IIb\/IIIa antagonist tirofiban and heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II","volume":"122","author":"Koster","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib22","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.athoracsur.2017.06.031","article-title":"Abciximab\/heparin therapy for left ventricular assist device implantation in patients with heparin-induced thrombocytopenia","volume":"105","author":"Lee","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib23","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1053\/j.semtcvs.2019.10.002","article-title":"Novel use of cangrelor with heparin during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia who require cardiovascular surgery: a case series","volume":"32","author":"Gernhofer","year":"2020","journal-title":"Semin Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib24","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jtcvs.2003.08.042","article-title":"Preoperative detection and management of immune heparin-induced thrombocytopenia in patients undergoing heart surgery with iloprost","volume":"127","author":"Palatianos","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib25","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00000542-200102000-00013","article-title":"Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban","volume":"94","author":"Koster","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jtha.2026.05.029_bib26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0022-5223(19)38447-8","article-title":"Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation","volume":"87","author":"Olinger","year":"1984","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1056\/NEJM200008173430718","article-title":"Use of heparin during cardiopulmonary bypass in patients with a history of heparin-induced thrombocytopenia","volume":"343","author":"Potzsch","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.029_bib28","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1213\/00000539-200302000-00009","article-title":"Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series","volume":"96","author":"Nuttall","year":"2003","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jtha.2026.05.029_bib29","doi-asserted-by":"crossref","first-page":"4024","DOI":"10.1182\/blood-2008-03-145243","article-title":"Management of anticoagulation in patients with subacute heparin-induced thrombocytopenia scheduled for heart transplantation","volume":"112","author":"Selleng","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.029_bib30","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood-2013-10-533083","article-title":"Serological investigation of patients with a previous history of heparin-induced thrombocytopenia who are reexposed to heparin","volume":"123","author":"Warkentin","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.029_bib31","first-page":"757","article-title":"Treating heparin-induced thrombocytopenia in patients undergoing HeartMate 3 left ventricular assist device implantation","volume":"25","author":"Eisenberger","year":"2023","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.jtha.2026.05.029_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.healun.2009.08.016","article-title":"Cardiac transplantation and\/or mechanical circulatory support device placement using heparin anti-coagulation in the presence of acute heparin-induced thrombocytopenia","volume":"29","author":"Zucker","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jtha.2026.05.029_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1525-1594.2009.00961.x","article-title":"The use of bivalirudin for cardiopulmonary bypass anticoagulation in pediatric heparin-induced thrombocytopenia patients","volume":"34","author":"Gates","year":"2010","journal-title":"Artif Organs"},{"key":"10.1016\/j.jtha.2026.05.029_bib34","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/0267659118767374","article-title":"Comparison of two pediatric cases requiring the use of bivalirudin during cardiopulmonary bypass","volume":"33","author":"Bryant","year":"2018","journal-title":"Perfusion"},{"key":"10.1016\/j.jtha.2026.05.029_bib35","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1051\/ject\/201244069","article-title":"Alternative anticoagulation during cardiovascular procedures in pediatric patients with heparin-induced thrombocytopenia","volume":"44","author":"Argueta-Morales","year":"2012","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.jtha.2026.05.029_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MBC.0000000000001193","article-title":"Cangrelor for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: it is not so easy","volume":"34","author":"Godier","year":"2023","journal-title":"Blood Coagul Fibrinolysis Int J Haemost Thromb"},{"key":"10.1016\/j.jtha.2026.05.029_bib37","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1160\/TH11-09-0677","article-title":"Heparin-induced thrombocytopenia (HIT) in 2011: an epidemic of overdiagnosis","volume":"106","author":"Cuker","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.029_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13613-025-01447-x","article-title":"Thrombocytopenia in the intensive care unit: diagnosis and management","volume":"15","author":"P\u00e8ne","year":"2025","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.jtha.2026.05.029_bib39","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1538-7836.2006.01787.x","article-title":"Evaluation of pretest clinical score (4 T\u2019s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings","volume":"4","author":"Lo","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.029_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2014.02.004","article-title":"Heparin-induced thrombocytopenia in the critically ill: interpreting the 4Ts test in a randomized trial","volume":"29","author":"Crowther","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/j.jtha.2026.05.029_bib41","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1111\/j.1538-7836.2004.00949.x","article-title":"Diagnostic score for heparin-induced thrombocytopenia after cardiopulmonary bypass","volume":"2","author":"Lillo-Le Lou\u00ebt","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.029_bib42","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/bloodadvances.2018023077","article-title":"Prospective comparison of the HEP score and 4Ts score for the diagnosis of heparin-induced thrombocytopenia","volume":"2","author":"Pishko","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.05.029_bib43","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ajh.24979","article-title":"Laboratory tests for identification or exclusion of heparin induced thrombocytopenia: HIT or miss?","volume":"93","author":"Favaloro","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.029_bib44","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/bjh.19180","article-title":"Diagnosis and management of heparin-induced thrombocytopenia: Third edition","volume":"204","author":"Arachchillage","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.05.029_bib45","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/01.CIR.95.5.1242","article-title":"Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery","volume":"95","author":"Bauer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.05.029_bib46","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.athoracsur.2006.09.040","article-title":"Prevalence of heparin\/platelet factor 4 antibodies before and after cardiac surgery","volume":"83","author":"Everett","year":"2007","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib47","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1378\/chest.12-2712","volume":"144","author":"Raschke","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.029_bib48","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.thromres.2017.03.010","article-title":"Performance characteristics of an automated latex immunoturbidimetric assay [HemosIL \u00ae HIT-Ab (PF4-H)] for the diagnosis of immune heparin-induced thrombocytopenia","volume":"153","author":"Warkentin","year":"2017","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.05.029_bib49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ajh.25660","article-title":"Serotonin-release assay-negative heparin-induced thrombocytopenia","volume":"95","author":"Warkentin","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2026.05.029_bib50","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1056\/NEJM200104263441704","article-title":"Temporal aspects of heparin-induced thrombocytopenia","volume":"344","author":"Warkentin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.05.029_bib51","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/0003-4975(92)91437-E","article-title":"Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition","volume":"53","author":"Walls","year":"1992","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2026.05.029_bib52","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1378\/chest.129.5.1167","article-title":"Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction","volume":"129","author":"Levine","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.029_bib53","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1051\/ject\/200537296","article-title":"Use of bivalirudin as an anticoagulant during cardiopulmonary bypass","volume":"37","author":"Veale","year":"2005","journal-title":"J Extra Corpor Technol"},{"key":"10.1016\/j.jtha.2026.05.029_bib54","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1182\/blood-2017-08-803031","article-title":"Normal plasma IgG inhibits HIT antibody\u2013mediated platelet activation: implications for therapeutic plasma exchange","volume":"131","author":"Jones","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.029_bib55","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1182\/blood-2014-07-590844","article-title":"Plasma exchange to remove HIT antibodies: dissociation between enzyme-immunoassay and platelet activation test reactivities","volume":"125","author":"Warkentin","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.05.029_bib56","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1111\/jth.13813","article-title":"Autoimmune heparin-induced thrombocytopenia","volume":"15","author":"Greinacher","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.05.029_bib57","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.seminhematol.2022.02.005","article-title":"Platelet-activating anti-PF4 disorders: an overview","volume":"59","author":"Warkentin","year":"2022","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtha.2026.05.029_bib58","doi-asserted-by":"crossref","first-page":"e89S","DOI":"10.1378\/chest.11-2293","article-title":"Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Eikelboom","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.05.029_bib59","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1053\/j.jvca.2024.09.006","article-title":"Efficacy of therapeutic plasma exchange or cangrelor as an adjunctive strategy to facilitate cardiopulmonary bypass in patients with heparin-induced thrombocytopenia: a systematic review and meta-analysis","volume":"38","author":"Del Vecchio","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jtha.2026.05.029_bib60","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1182\/hematology.2021000289","article-title":"Heparin-induced thrombocytopenia and cardiovascular surgery","volume":"2021","author":"Pishko","year":"2021","journal-title":"Hematology Am Soc Hematol Educ Program"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626003533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:29:00Z","timestamp":1787153340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626003533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1538783626003533"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.029","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of anticoagulation in patients with heparin-induced thrombocytopenia requiring cardiac surgery with cardiopulmonary bypass: guidance from the ISTH SSC on Perioperative and Critical Care Haemostasis and Thrombosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}